CIK 0001676725 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 218.7 M | 50.9 M | ||
| Net income (USD) | -34.5 M | -42.0 M | ||
| Diluted EPS (USD/shares) | -1.28 | -1.42 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-08 | 4 | FORM 4 | 2026-10-06 |
| 2026-10-06 | 144 | 144 | |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-07-31 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-09 | 4 | FORM 4 | 2026-07-07 |
| 2026-07-07 | 144 | 144 | |
| 2026-06-23 | 8-K | 8-K items 5.07,8.01 | 2026-06-16 |
| 2026-06-18 | 4 | 4 | 2026-06-16 |
| 2026-06-18 | 4 | 4 | 2026-06-16 |
| 2026-06-18 | 4 | 4 | 2026-06-16 |
| 2026-06-18 | 4 | 4 | 2026-06-16 |
| 2026-06-18 | 4 | 4 | 2026-06-16 |
| 2026-06-18 | 4 | 4 | 2026-06-16 |
| 2026-06-10 | 8-K | 8-K items 8.01,9.01 | 2026-06-08 |
| 2026-06-09 | 424B5 | 424B5 | |
| 2026-06-08 | 424B5 | 424B5 | |
| 2026-06-05 | 3 | 3 | 2026-03-18 |
| 2026-06-03 | 8-K | 8-K items 8.01 | 2026-06-03 |
| 2026-06-01 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-06-01 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-05 | 8-K | 8-K items 8.01,9.01 | 2026-05-05 |
| 2026-05-05 | 424B5 | 424B5 | |
| 2026-05-05 | S-3ASR | S-3ASR |
Forms on file (last 1,000): 4 167, 8-K 104, SC 13G/A 32, 3 28, 10-Q 22, SC 13G 22, 144 21, 424B5 19. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=IDYA (0.002 USD), /gw/filings/filings?ticker=IDYA&form=8-K, /gw/filings/facts?ticker=IDYA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange